Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153209620> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2153209620 endingPage "40" @default.
- W2153209620 startingPage "38v" @default.
- W2153209620 abstract "Primary (AL) and secondary (AA) amyloidosis are systemic diseases characterized by a process of amyloid deposition in many organs with unsatisfactory survival of patients. Apart from surgical intervention in those patients with bronchiectasias or osteomyelitis, the possibilities of influencing the development of AA amyloidosis are limited. The milestone therapy in patients with rheumatic diseases includes early treatment with DMARDs (disease-modifying antirheumatic drugs). A new promising therapeutic alternative is represented by anti-tumour necrosis factor-α (TNF-α) drugs such as infliximab and etanercept. The last class of agents used in the treatment of AA interferes with fibril formation: iododoxorubicin and low molecular weight sulfates (fibrilex). In the group of patients with AL, in addition to the standard combination of melphalan and prednisone, other therapeutic approaches such as ASCT (autologous stem cell transplantation) and new drugs with different mechanisms of action have been added recently. For the future, we can expect the development of immunotherapy (both active vaccination and passive immunization). In our department, we have treated 17 patients with AL and 14 patients with AA amyloidosis since 1995. We used various treatment regimens in both groups of patients. The treatment stabilized the disease or achieved partial remission in only 36% of patients with AA amyloidosis despite the use of intensive therapeutic modalities, while in the AL group a response was achieved in 82% of patients. ASCT improves patients survival in AL amyloidosis, but strict selection criteria are necessary (less than two affected organs and no signs of myocardial dysfunction)." @default.
- W2153209620 created "2016-06-24" @default.
- W2153209620 creator A5016613978 @default.
- W2153209620 creator A5030524608 @default.
- W2153209620 creator A5045895952 @default.
- W2153209620 creator A5081888215 @default.
- W2153209620 date "2003-07-01" @default.
- W2153209620 modified "2023-10-18" @default.
- W2153209620 title "Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients" @default.
- W2153209620 cites W1969214107 @default.
- W2153209620 cites W1971828262 @default.
- W2153209620 cites W1999519330 @default.
- W2153209620 cites W206392377 @default.
- W2153209620 cites W2071826726 @default.
- W2153209620 cites W2106283558 @default.
- W2153209620 cites W2160440431 @default.
- W2153209620 cites W2357045845 @default.
- W2153209620 cites W24331275 @default.
- W2153209620 cites W86094332 @default.
- W2153209620 cites W2341574028 @default.
- W2153209620 cites W2589838108 @default.
- W2153209620 doi "https://doi.org/10.1093/ndt/gfg1043" @default.
- W2153209620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12817067" @default.
- W2153209620 hasPublicationYear "2003" @default.
- W2153209620 type Work @default.
- W2153209620 sameAs 2153209620 @default.
- W2153209620 citedByCount "16" @default.
- W2153209620 countsByYear W21532096202012 @default.
- W2153209620 countsByYear W21532096202019 @default.
- W2153209620 crossrefType "journal-article" @default.
- W2153209620 hasAuthorship W2153209620A5016613978 @default.
- W2153209620 hasAuthorship W2153209620A5030524608 @default.
- W2153209620 hasAuthorship W2153209620A5045895952 @default.
- W2153209620 hasAuthorship W2153209620A5081888215 @default.
- W2153209620 hasBestOaLocation W21532096201 @default.
- W2153209620 hasConcept C126322002 @default.
- W2153209620 hasConcept C141071460 @default.
- W2153209620 hasConcept C143998085 @default.
- W2153209620 hasConcept C159654299 @default.
- W2153209620 hasConcept C203014093 @default.
- W2153209620 hasConcept C2777138892 @default.
- W2153209620 hasConcept C2777226972 @default.
- W2153209620 hasConcept C2777575956 @default.
- W2153209620 hasConcept C2778684742 @default.
- W2153209620 hasConcept C2779050716 @default.
- W2153209620 hasConcept C2779134260 @default.
- W2153209620 hasConcept C2779551797 @default.
- W2153209620 hasConcept C2779951007 @default.
- W2153209620 hasConcept C2911091166 @default.
- W2153209620 hasConcept C36394416 @default.
- W2153209620 hasConcept C71924100 @default.
- W2153209620 hasConceptScore W2153209620C126322002 @default.
- W2153209620 hasConceptScore W2153209620C141071460 @default.
- W2153209620 hasConceptScore W2153209620C143998085 @default.
- W2153209620 hasConceptScore W2153209620C159654299 @default.
- W2153209620 hasConceptScore W2153209620C203014093 @default.
- W2153209620 hasConceptScore W2153209620C2777138892 @default.
- W2153209620 hasConceptScore W2153209620C2777226972 @default.
- W2153209620 hasConceptScore W2153209620C2777575956 @default.
- W2153209620 hasConceptScore W2153209620C2778684742 @default.
- W2153209620 hasConceptScore W2153209620C2779050716 @default.
- W2153209620 hasConceptScore W2153209620C2779134260 @default.
- W2153209620 hasConceptScore W2153209620C2779551797 @default.
- W2153209620 hasConceptScore W2153209620C2779951007 @default.
- W2153209620 hasConceptScore W2153209620C2911091166 @default.
- W2153209620 hasConceptScore W2153209620C36394416 @default.
- W2153209620 hasConceptScore W2153209620C71924100 @default.
- W2153209620 hasIssue "90005" @default.
- W2153209620 hasLocation W21532096201 @default.
- W2153209620 hasLocation W21532096202 @default.
- W2153209620 hasOpenAccess W2153209620 @default.
- W2153209620 hasPrimaryLocation W21532096201 @default.
- W2153209620 hasRelatedWork W1980048113 @default.
- W2153209620 hasRelatedWork W2002099958 @default.
- W2153209620 hasRelatedWork W2003499126 @default.
- W2153209620 hasRelatedWork W2012879531 @default.
- W2153209620 hasRelatedWork W2034080653 @default.
- W2153209620 hasRelatedWork W2039532382 @default.
- W2153209620 hasRelatedWork W2046328177 @default.
- W2153209620 hasRelatedWork W2081068834 @default.
- W2153209620 hasRelatedWork W2563227149 @default.
- W2153209620 hasRelatedWork W3014946275 @default.
- W2153209620 hasVolume "18" @default.
- W2153209620 isParatext "false" @default.
- W2153209620 isRetracted "false" @default.
- W2153209620 magId "2153209620" @default.
- W2153209620 workType "article" @default.